Long-Term Combined Training in Idiopathic Pulmonary Fibrosis: A Case Study

被引:7
|
作者
Naranjo-Orellana, Jose [1 ]
Santalla, Alfredo [1 ,2 ]
机构
[1] Pablo de Olavide Univ, Dept Sport & Comp, Seville 41013, Spain
[2] Inst Invest Hosp 12 Octubre I 12, Madrid 28041, Spain
关键词
inspiratory muscle training; resistance training; idiopathic pulmonary fibrosis; LUNG TRANSPLANTATION; INSPIRATORY MUSCLE; VENTILATORY EFFICIENCY; ARTERIAL-HYPERTENSION; EXERCISE CAPACITY; PHYSICAL-ACTIVITY; REHABILITATION; BENEFITS; OUTCOMES;
D O I
10.3390/ijerph17145091
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
A supervised combined training program was applied to a sedentary 56-year-old man with idiopathic pulmonary fibrosis (IPF) along three years, until lung transplantation. It included: (a) aerobic continuous (CT) and interval training (IT), (b) high load resistance training (RT) and (c) inspiratory muscle training (IMT). IT and IMT were applied for two years, while CT and RT could be maintained until transplantation using supplemental oxygen. Maximal inspiratory pressure (MIP) kept above 180 cm H2O and forced vital capacity (FVC) remained stable until lung transplantation. Peak oxygen uptake VO(2)increased during 1.5 years before its decline, staying above the poor prognosis level two years. Finally, the patient maintained his walking capacity and independence for 2 years, before the decline due to the disease. After receiving a two-lung transplant, the patient remained intubated for 12 h, left the intensive care unit after 3.5 days and was discharged after 18 days (average values: 48 h, 7-10 days and 25-35 days, respectively). These results show that systematic and supervised combined training can be safety applied in an IPF patient to maintain functionality and quality of life. In addition, we show that RT can be maintained for as long as necessary without complications.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 50 条
  • [21] LONG-TERM PULMONARY FUNCTION AND MORTALITY OUTCOMES IN IDIOPATHIC PULMONARY FIBROSIS PATIENTS TREATED WITH ANTIFIBROTICS
    Barnes, J.
    Harris, E.
    Matos, L.
    Harding, K.
    Thillai, M.
    THORAX, 2021, 76 : A147 - A148
  • [22] An Open-Label Study of the Long-Term Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (RECAP)
    Costabel, Ulrich
    Albera, Carlo
    Lancaster, Lisa H.
    Lin, Chin-Yu
    Hormel, Philip
    Hulter, Henry N.
    Noble, Paul W.
    RESPIRATION, 2017, 94 (05) : 408 - 415
  • [23] Patterns of discontinuation in the long-term RECAP study of pirfenidone (PFD) in patients with idiopathic pulmonary fibrosis (IPF)
    Costabel, Ulrich
    Albera, Carlo
    Lancaster, Lisa H.
    de Andrade, Joao A.
    Trzaskoma, Benjamin
    Limb, Susan
    Noble, Paul W.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [24] IDIOPATHIC RETROPERITONEAL FIBROSIS - A LONG-TERM FOLLOW-UP-STUDY
    ALEXOPOULOS, E
    MEMMOS, D
    BAKATSELOS, S
    ROMBIS, V
    SAKELLARIOU, G
    GAGANAKIS, J
    HADJIDIMITRIOU, C
    PAPADIMITRIOU, M
    EUROPEAN UROLOGY, 1987, 13 (05) : 313 - 317
  • [25] A rare case of long-term survival with idiopathic dilatation of the pulmonary artery
    Sueta, Daisuke
    Sugamura, Koichi
    Shimizu, Hiroshi
    Shiota, Takuya
    Yamamuro, Megumi
    Hirakawa, Kyoko
    Sakamoto, Kenji
    Tsujita, Kenichi
    Hanatani, Shinsuke
    Yamamoto, Eiichiro
    Araki, Satoshi
    Kanazawa, Hisanori
    Kojima, Sunao
    Kaikita, Koichi
    Hokimoto, Seiji
    Komohara, Yoshihiro
    Ogawa, Hisao
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 223 : 337 - 339
  • [26] Long-Term Treatment with Nintedanib for Idiopathic Pulmonary Fibrosis in a Real-World Setting
    Kato, M.
    Sasaki, S.
    Arai, Y.
    Motomura, H.
    Sumiyoshi, I.
    Ochi, Y.
    Watanabe, J.
    Ihara, H.
    Togo, S.
    Takahashi, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [27] Prevalence and predictors of response to long-term treatment in patients with idiopathic pulmonary fibrosis (IPF).
    Cocconcelli, Elisabetta
    Bernardinello, Nicol
    Cameli, Paolo
    Pianigiani, Tommaso
    Di Liberti, Rosangela
    Dartora, Cristina
    Messina, Riccardo
    Di Leo, Irene
    La Blasca, Tiziana
    Scichilone, Nicola
    Bargagli, Elena
    Saetta, Marina
    Spagnolo, Paolo
    Balestro, Elisabetta
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [28] Long-Term Efficacy of Inhaled N-Acetylcysteine in Patients with Idiopathic Pulmonary Fibrosis
    Bando, Masashi
    Hosono, Tatsuya
    Mato, Naoko
    Nakaya, Takakiyo
    Yamasawa, Hideaki
    Ohno, Shoji
    Sugiyama, Yukihiko
    INTERNAL MEDICINE, 2010, 49 (21) : 2289 - 2296
  • [29] Safety and Tolerability of Long-term Treatment with Aerosolized Interferon Gamma in Idiopathic Pulmonary Fibrosis
    Bauer, K.
    Diaz, K.
    Morra, L.
    Smaldone, G.
    Condos, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [30] Serum level of periostin can predict long-term outcome of idiopathic pulmonary fibrosis
    Tajiri, Morihiro
    Okamoto, Masaki
    Fujimoto, Kiminori
    Johkoh, Takeshi
    Ono, Junya
    Tominaga, Masaki
    Azuma, Koichi
    Kawayama, Tomotaka
    Ohta, Shoichiro
    Izuhara, Kenji
    Hoshino, Tomoaki
    RESPIRATORY INVESTIGATION, 2015, 53 (02) : 73 - 81